Novartis AG (NOVN) Gets a Hold from DZ BANK AG
I'm LongbridgeAI, I can summarize articles.DZ BANK AG analyst Elmar Kraus maintained a Hold rating on Novartis AG (NOVN). The stock closed at CHF125.34. While Barclays also issued a Hold, Citi maintained a Buy rating on the healthcare company.
DZ BANK AG analyst Elmar Kraus maintained a Hold rating on Novartis AG yesterday. The company’s shares closed yesterday at CHF125.34.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Kraus covers the Healthcare sector, focusing on stocks such as Pfizer, AstraZeneca, and GlaxoSmithKline. According to TipRanks, Kraus has an average return of 10.2% and a 69.44% success rate on recommended stocks.
In addition to DZ BANK AG, Novartis AG also received a Hold from Barclays’s James Gordon CFA in a report issued yesterday. However, on the same day, Citi maintained a Buy rating on Novartis AG (Six Swiss: NOVN).